Inventor · disambiguated record
Yoon Jeon
Also filed as: JEON YOON · JEON YOON T · JEON YOON-TAE
46 granted patents·4 pending applications·1,192 citations·filing 1996–2021
98Inventor score
Files withBRISTOL MYERS SQUIBB CO21SYNAPTIC PHARMA CORP21ICAGEN INC2AEKYUNG CHEMICAL CO LTD1BRISTOL MEYERS SQUIBB CO1
Top patents by PatentIndex Score
50 records- 0198US6727271B2Substituted acid derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Apr 27, 2004·92 cites·19 claims
- 0298US6414002B1Substituted acid derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jul 2, 2002·204 cites·30 claims
- 0397US7005436B2Heterocyclo inhibitors of potassium channel functionICAGEN INC·Filed 2003·Granted Feb 28, 2006·149 cites·15 claims
- 0497US6653314B2Substituted acid derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Nov 25, 2003·67 cites·13 claims
- 0596US6673815B2Substituted acid derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jan 6, 2004·98 cites·35 claims
- 0696US6391877B1Aryl sulfonamides and sulfamide derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 2000·Granted May 21, 2002·52 cites·39 claims
- 0795US6723741B2Benzimidazoles and benzothiazoles and uses thereofSYNAPTIC PHARMA CORP·Filed 2002·Granted Apr 20, 2004·46 cites·17 claims
- 0895US6620815B1Oxazolidinones and uses thereofSYNAPTIC PHARMA CORP·Filed 2000·Granted Sep 16, 2003·50 cites·40 claims
- 0994US6211241B1Aryl sulfonamides and sulfamide derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 1998·Granted Apr 3, 2001·58 cites·11 claims
- 1093US7915410B2Acyclic IKur inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Mar 29, 2011·20 cites·2 claims
- 1192US7452907B2Conformationally constrained analogs useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Nov 18, 2008·21 cites·16 claims
- 1291US10487086B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Nov 26, 2019·3 cites·9 claims
- 1391US8940720B2Macrocycles as factor XIa inhibitorsCORTE JAMES R·Filed 2011·Granted Jan 27, 2015·6 cites·4 claims
- 1491US6159998ASubstituted indoles and uses thereofSYNAPTIC PHARMA CORP·Filed 2000·Granted Dec 12, 2000·30 cites·13 claims
- 1589US9802939B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Oct 31, 2017·3 cites·9 claims
- 1688US7202253B2Cycloalkyl inhibitors of potassium channel functionICAGEN INC·Filed 2004·Granted Apr 10, 2007·27 cites·9 claims
- 1788US6919358B2Substituted acid derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MEYERS SQUIBB CO·Filed 2002·Granted Jul 19, 2005·12 cites·14 claims
- 1887US6495583B1Benzimidazole derivativesSYNAPTIC PHARMA CORP·Filed 2002·Granted Dec 17, 2002·14 cites·13 claims
- 1986US11136327B2Macrocycles as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Oct 5, 2021·1 cites·11 claims
- 2086US7053106B2Substituted acid derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 30, 2006·10 cites·26 claims
- 2185US6159990AOxazolidinones as α1A receptor antagonistsSYNAPTIC PHARMA CORP·Filed 1998·Granted Dec 12, 2000·66 cites·38 claims
- 2284US5677321A5- and 6-(2-imidazolin-2-ylamino) and -(2-thiazolin-2-ylamino)-benzothiazoles as alpha-2 adrenergic ligandsSYNAPTIC PHARMA CORP·Filed 1996·Granted Oct 14, 1997·38 cites·16 claims
- 2382US7582654B2Heterocyclo inhibitors of potassium channel functionBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Sep 1, 2009·4 cites·4 claims
- 2482US5948804ASubstituted indoles and uses thereofSYNAPTIC PHARMA CORP·Filed 1997·Granted Sep 7, 1999·33 cites·12 claims
- 2580US12404274B2Macrocycles as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 2, 2025·0 cites·8 claims
- 2680US6040451ASubstituted indoles and uses thereofSYNAPTIC PHARMA CORP·Filed 1999·Granted Mar 21, 2000·29 cites·22 claims
- 2777US7105556B2Conformationally constrained analogs useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Sep 12, 2006·9 cites·17 claims
- 2877US7084162B2Substituted acid derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 1, 2006·4 cites·3 claims
- 2975US8357809B2Acyclic IKur inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2011·Granted Jan 22, 2013·2 cites·2 claims
- 3075US6498177B2Indole and benzothiazole derivativesSYNAPTIC PHARMA CORP·Filed 2001·Granted Dec 24, 2002·4 cites·20 claims
- 3173US6777426B2Imidazole and imidazoline derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 2001·Granted Aug 17, 2004·4 cites·12 claims
- 3269US6303643B1Substituted indoles and uses thereofSYNAPTIC PHARMA CORP·Filed 2000·Granted Oct 16, 2001·2 cites·17 claims
- 3366US9738655B2Tetrahydroisoquinolines containing substituted azoles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 22, 2017·1 cites·15 claims
- 3466US6316637B1Benzimidazole derivativesSYNAPTIC PHARMA CORP·Filed 1999·Granted Nov 13, 2001·8 cites·20 claims
- 3565US2009312307A1Heterocyclo inhibitors of potassium channel functionBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 3664US8901115B2Cyclic P1 linkers as factor XIa inhibitorsLAM PATRICK Y S·Filed 2012·Granted Dec 2, 2014·1 cites·12 claims
- 3764US7241780B2Substituted acid derivatives useful as antidiabetic and antiobesity agents and methodBRISTOLS MYERS SQUIBB COMPANY·Filed 2004·Granted Jul 10, 2007·2 cites·38 claims
- 3863US6436982B1Benzimidazole derivativesSYNAPTIC PHARMA CORP·Filed 2001·Granted Aug 20, 2002·1 cites·3 claims
- 3961US6403626B1Benzimidazole derivativesSYNAPTIC PHARMA CORP·Filed 2001·Granted Jun 11, 2002·1 cites·20 claims
- 4058US2007142333A1Cycloalkyl inhibitors of potassium channel functionBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 4157US5866579AImidazole and imidazoline derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 1997·Granted Feb 2, 1999·9 cites·8 claims
- 4256US9108981B2Cyclic P1 linkers as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 18, 2015·0 cites·11 claims
- 4353US6093727AImidazole and imidazoline derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 1998·Granted Jul 25, 2000·7 cites·14 claims
- 4452US2004072880A1Cycloalkyl inhibitors of potassium channel functionFiled 2003·Application pending·0 cites
- 4549US6734182B2Aryl sulfonamides and sulfamide derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 2002·Granted May 11, 2004·0 cites·25 claims
- 4648US2003181730A1Novel benzimidazole derivativesSYNAPTIC PHARMA CORP·Filed 2002·Application pending·0 cites
- 4746US6294566B1Imidazoline derivatives and uses thereofSYNAPTIC PHARMA CORP·Filed 1999·Granted Sep 25, 2001·4 cites·18 claims
- 4845US9428504B27-hydroxy-spiropipiperidine indolinyl antagonists of P2Y1 receptorBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Aug 30, 2016·0 cites·2 claims
- 4944US7579479B2Substituted acid derivatives useful as antidiabetic and antiobesity agents and methodBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 25, 2009·0 cites·9 claims
- 5034US9434682B2Reactive mesogen compound having superior thermostability and high birefringence and method of preparing the sameAEKYUNG CHEMICAL CO LTD·Filed 2015·Granted Sep 6, 2016·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Yoon Jeon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →